Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders.
OBJECTIVE
The aim of this study was to investigate the short-term efficacy and safety of methylphenidate (MPH) to treat attention-deficit/hyperactivity disorder (ADHD) symptoms in an understudied population of preschoolers with pervasive developmental disorder (PDD) or intellectual disability (ID).


METHODS
Fourteen preschoolers with developmental disorders (DD, n = 14; PDD, n = 12; ID, n = 2) underwent MPH titration in a single-blind manner followed by a 4-week double-blind crossover phase. Each child was administered placebo for 2 weeks and "optimal dose" for 2 weeks. The primary outcome measure was the Diagnostic and Statistical Manual of Mental Disorders, 4(th) edition (DSM-IV) ADHD subscale of the Conners' Parent Rating Scale-Revised (CPRS-R-DSM-IV-ADHD).


RESULTS
MPH improved parent-rated ADHD symptoms of the preschoolers; 50% were rated as responders. The CPRS-R-DSM-IV-ADHD subscale was significant for the PDD subgroup (p = 0.005, Cohen d = 0.97) and marginally significant for the entire DD sample (p = 0.08, Cohen d = 0.50). Half of the preschoolers experienced side effects with MPH, including reports of increased stereotypic behavior, upset stomach, sleep-related difficulties, and emotional lability. One child discontinued during titration due to side effects.


CONCLUSIONS
The predominant direction of response in these preschoolers with both ADHD and PDD/ID favored MPH, even though the response was more subtle and variable than in older and typically developing children. Due to high rates of adverse effects, preschoolers should be monitored closely.
Ghuman
Jaswinder K
JK
University of Arizona , Child and Adolescent Psychiatry, Tucson, Arizona 85724-5002, USA. jkghuman@email.arizona.edu
Aman
Michael G
MG
Lecavalier
Luc
L
Riddle
Mark A
MA
Gelenberg
Alan
A
Wright
Ron
R
Rice
Sydney
S
Ghuman
Harinder S
HS
Fort
Carolyn
C
D000367:Age Factors; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology; D002659:Child Development Disorders, Pervasive / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology; D002675:Child, Preschool; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use*; D016037:Single-Blind Method
D008774:Methylphenidate
J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1114-23
16926619
J Autism Dev Disord. 2006 Nov;36(8):1101-14
16897387
J Am Acad Child Adolesc Psychiatry. 2001 May;40(5):516-24
11349695
Dev Med Child Neurol. 1994 Dec;36(12):1099-107
7525394
J Child Adolesc Psychopharmacol. 2005 Feb;15(1):116-26
15741793
Folia Psychiatr Neurol Jpn. 1977;31(4):605-14
608662
Psychiatry Res. 1991 Feb;36(2):141-55
2017529
J Autism Child Schizophr. 1972 Oct-Dec;2(4):343-58
4581614
J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1284-1293
17023867
J Am Acad Child Adolesc Psychiatry. 1988 Mar;27(2):248-51
3360732
Psychol Assess. 2005 Dec;17(4):486-91
16393016
Res Dev Disabil. 1996 Jan-Feb;17(1):41-57
8750075
J Child Adolesc Psychopharmacol. 2004 Summer;14(2):207-18
15319018
J Child Adolesc Psychopharmacol. 2007 Oct;17(5):563-80
17979578
J Child Adolesc Psychopharmacol. 2008 Oct;18(5):413-47
18844482
Curr Ther Res Clin Exp. 1976 Jan;19(1):70-86
812668
Res Dev Disabil. 2000 Nov-Dec;21(6):437-54
11153828
J Child Adolesc Psychopharmacol. 2007 Jun;17(3):348-55
17630868
J Am Acad Child Adolesc Psychiatry. 1999 Jul;38(7):805-12
10405497
Arch Gen Psychiatry. 2005 Nov;62(11):1266-74
16275814
J Child Adolesc Psychopharmacol. 2004 Winter;14(4):601-11
15662153
J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921
17581453
Arch Gen Psychiatry. 1983 Nov;40(11):1228-31
6639293
JAMA. 1982 Mar 26;247(12):1729-31
6950128
J Am Acad Child Adolesc Psychiatry. 1996 Apr;35(4):409-32
8919704
Pharmacol Biochem Behav. 1997 Dec;58(4):1095-102
9408219
J Child Adolesc Psychopharmacol. 2003 Spring;13(1):29-40
12804124
Arch Gen Psychiatry. 1999 Dec;56(12):1088-96
10591284
J Am Acad Child Adolesc Psychiatry. 1995 Dec;34(12):1672-81
8543539